Glenmark Pharmaceuticals receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Azelaic Acid Gel, 15% General Announcement Filing viewer · member access Original SGX announcement
GPL Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Teriflunomide Tablets, 7 mg and 14 mg General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches globally-renowned hair growth formula Nourkrin in Russia General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil) General Announcement Filing viewer · member access Original SGX announcement
Data on Glenmark Pharmaceuticals GBR 830 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Cream USP, 0.2% General Announcement Filing viewer · member access Original SGX announcement
ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE EQUITY-LINKED SECURITIES DUE 2022 General Announcement Filing viewer · member access Original SGX announcement
Update on intimation regarding the Orthopaedic Business General Announcement Filing viewer · member access Original SGX announcement
U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022 General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting to consider repurchase of Foreign Currency Debt General Announcement Filing viewer · member access Original SGX announcement
Outcome of Voting of Postal Ballot/E-Voting General Announcement Filing viewer · member access Original SGX announcement
Intimation of Board Meeting to consider repurchase of Foreign Currency Debt General Announcement Filing viewer · member access Original SGX announcement
GPL secures marketing authorization in Germany for Seretide Accuhaler General Announcement Filing viewer · member access Original SGX announcement
Notice Of 40Th Annual General Meeting To Be Held On September 28, 2018 General Announcement Filing viewer · member access Original SGX announcement
Notice for Postal Ballot evoting General Announcement Filing viewer · member access Original SGX announcement
Financial Result for quarter ended June 2018 General Announcement Filing viewer · member access Original SGX announcement
GPLs partner Elite Pharmaceuticals receives US FDA approval General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302 General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
GPL Announces Encouraging Phase 1 Results Supporting Biosimilarity Criteria for GBR 310 General Announcement Filing viewer · member access Original SGX announcement